Liposomes in gene therapy
Bodor, A.; Kutas, J.ö
Acta Pharmaceutica Hungarica 73(2): 115-122
2003
ISSN/ISBN: 0001-6659 PMID: 14702692 Document Number: 560219
The role of liposomes in gene therapy is surveyed. The liposome mediated gene transfer is assessed. Details are given on the properties of cathionic lipids, and attributes of the cathionic vesicules. Problems and solutions animal experiments and human researches are discussed on literature examples.
Document emailed within 1 workday
Related Documents
Costantini, V.; Allegrucci, M.; Paolucci, M.C.; Ricci, M.; Stabile, A.M.; Presilla, M.C.; Nenci, G.G. 1999: Gene therapy of critical ischemia of the legs. Improvement of genetic transfection efficiency of endothelial cells in vitro, using cationic liposomes and protamine sulfate Minerva Cardioangiologica 47(12): 662-663Yotsuyanagi, T.; Hazemoto, N. 1998: Cationic liposomes in gene delivery Nihon Rinsho. Japanese Journal of Clinical Medicine 56(3): 705-712
Xiong, F.; Mi, Z.; Gu, N. 2011: Cationic liposomes as gene delivery system: transfection efficiency and new application Die Pharmazie 66(3): 158-164
Venugopalan, P.; Jain, S.; Sankar, S.; Singh, P.; Rawat, A.; Vyas, S.P. 2002: PH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects Die Pharmazie 57(10): 659-671
Tong, X.W.; Engehausen, D.G.; Kaufman, R.H.; Agoulnik, I.; Contant, C.; Freund, C.T.; Oehler, M.K.; Kim, T.E.; Hasenburg, A.; Woo, S.L.; Kieback, D.G. 1998: Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy Anticancer Research 18(2a): 713-718
Dvorkin, V.M.; Galkina, I.L.; VidershaÄn, G.I. 1983: Incorporation of some glycoconjugates into the membrane of liposomes and interaction of ganglioside-containing liposomes with rat hepatocytes in vitro Biokhimiia 48(9): 1496-1504
Iurasov, V.V.; Kucherianu, V.G.; Kudrin, V.S.; Zhigal'tsev, I.V.; Nikushkin, E.V.; Sandalov, I.G.; Kaplun, A.P.; Shvets, V.I. 1997: The effect of prolonged parenteral administration of liposomes and L-Dopa incorporated into liposomes on metabolism of dopamine and its metabolites in the striatum of mice with experimental parkinsonian syndrome Biulleten' Eksperimental'noi Biologii i Meditsiny 123(2): 150-153
Krówczyński, L.; Stozek, T. 1984: Liposomes as drug vehicles in percutaneous therapy Die Pharmazie 39(9): 627-629
Sasaki, S.; Kojima, Y.; Kubota, H.; Tatsura, H.; Hayashi, Y.; Kohri, K. 2000: Effects of the gene transfer into sperm mediated by liposomes on sperm motility and fertilization in vitro Hinyokika Kiyo. Acta Urologica Japonica 46(8): 591-595
Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267
Kulikov, V.I.; Kashkin, K.P.; Dranovskaia, E.A. 1985: Incorporation of the protective antigen of Brucella abortus into liposomes and the immunogenic properties of the antigen-containing liposomes Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 12: 69-72
Yamamoto, K.; Mizutani, Y.; Nakanishi, H.; Fujiwara, J.; Ishida, H.; Toiyama, D.; Abe, K.; Hayashi, I.; Okada, K.; Kawauchi, A.; Mizuno, M.; Yoshida, J.; Miki, T. 2008: Significant antitumor activity of cationic multilamellar liposomes containing human interferon-beta gene in combination with 5-fluorouracil against human renal cell carcinoma International Journal of Oncology 33(3): 565-571
BubenÃk, J.; Zeuthen, J.; BubenÃková, D.; SÃmová, J.; Jandlová, T. 1993: Gene therapy of cancer: use of IL-2 gene transfer and kinetics of local T and NK cell subsets Anticancer Research 13(5a): 1457-1460
Guo, M.-g.; Jiang, M.-h.; Yang, Q.; Li, Y.-m.; Cui, Z.-f.; Li, L.-f.; Wu, M.-c.; Qian, Q.-j. 2004: Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene Zhonghua Yi Xue Za Zhi 84(14): 1147-1151
Yoon, S.J.; Heo, D.S.; Kang, J.O.; Kim, N.K. 1999: Combination gene therapy of IL-12 and allogeneic MHC class i gene via stimulating NK cytolytic activity Anticancer Research 19(5b): 4337-4342
Grgić, M. 2000: Gene therapy of tumors of the head and neck: clinical use of the p53 tumor suppressor gene Lijecnicki Vjesnik 122(1-2): 14-16
Cooper, M.J. 1996: Noninfectious gene transfer and expression systems for cancer gene therapy Seminars in Oncology 23(1): 172-187
Kaneda, Y.; Morishita, R. 1997: Development of in vivo gene transfer methods towards future gene therapy Rinsho Byori. Japanese Journal of Clinical Pathology 45(2): 99-105
Bellon, G. 1998: From gene transfer to gene therapy in cystic fibrosis, how long is the road? La Revue du Praticien 48(1): 5-8
Zentilin, L.; Tafuro, S.; Serra, C.; Falaschi, A.; Giacca, M. 1998: Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells Annali Dell'istituto Superiore di Sanita 34(4): 447-455